vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $121.1M, roughly 1.6× Porch Group, Inc.). Porch Group, Inc. runs the higher net margin — -3.9% vs -14.6%, a 10.7% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 65.0%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 26.4%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
AXSM vs PRCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $121.1M |
| Net Profit | $-28.6M | $-4.7M |
| Gross Margin | — | 52.7% |
| Operating Margin | -13.8% | — |
| Net Margin | -14.6% | -3.9% |
| Revenue YoY | 65.0% | 100.0% |
| Net Profit YoY | 61.9% | 2.0% |
| EPS (diluted) | $-0.55 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $121.1M | ||
| Q4 25 | $196.0M | $112.3M | ||
| Q3 25 | $171.0M | $115.1M | ||
| Q2 25 | $150.0M | $107.0M | ||
| Q1 25 | $121.5M | $84.5M | ||
| Q4 24 | $118.8M | $75.3M | ||
| Q3 24 | $104.8M | $77.7M | ||
| Q2 24 | $87.2M | $75.9M |
| Q1 26 | — | $-4.7M | ||
| Q4 25 | $-28.6M | $-3.5M | ||
| Q3 25 | $-47.2M | $-10.9M | ||
| Q2 25 | $-48.0M | $2.6M | ||
| Q1 25 | $-59.4M | $8.4M | ||
| Q4 24 | $-74.9M | $30.5M | ||
| Q3 24 | $-64.6M | $14.4M | ||
| Q2 24 | $-79.3M | $-64.3M |
| Q1 26 | — | 52.7% | ||
| Q4 25 | — | 99.5% | ||
| Q3 25 | — | 75.6% | ||
| Q2 25 | — | 70.9% | ||
| Q1 25 | — | 77.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 79.4% | ||
| Q2 24 | — | 22.1% |
| Q1 26 | — | — | ||
| Q4 25 | -13.8% | 14.7% | ||
| Q3 25 | -27.0% | 14.2% | ||
| Q2 25 | -24.5% | 4.7% | ||
| Q1 25 | -46.9% | -1.5% | ||
| Q4 24 | -61.1% | 33.3% | ||
| Q3 24 | -59.8% | -3.2% | ||
| Q2 24 | -89.5% | -69.2% |
| Q1 26 | — | -3.9% | ||
| Q4 25 | -14.6% | -3.1% | ||
| Q3 25 | -27.6% | -9.4% | ||
| Q2 25 | -32.0% | 2.4% | ||
| Q1 25 | -48.9% | 9.9% | ||
| Q4 24 | -63.1% | 40.5% | ||
| Q3 24 | -61.7% | 18.5% | ||
| Q2 24 | -91.0% | -84.8% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $-0.55 | $0.00 | ||
| Q3 25 | $-0.94 | $-0.10 | ||
| Q2 25 | $-0.97 | $0.00 | ||
| Q1 25 | $-1.22 | $0.07 | ||
| Q4 24 | $-1.54 | $0.34 | ||
| Q3 24 | $-1.34 | $0.12 | ||
| Q2 24 | $-1.67 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $68.4M |
| Total DebtLower is stronger | — | $391.3M |
| Stockholders' EquityBook value | $88.3M | $26.3M |
| Total Assets | $689.8M | $806.6M |
| Debt / EquityLower = less leverage | — | 14.87× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $68.4M | ||
| Q4 25 | $322.9M | $57.3M | ||
| Q3 25 | $325.3M | $85.0M | ||
| Q2 25 | $303.0M | $79.8M | ||
| Q1 25 | $300.9M | $70.4M | ||
| Q4 24 | $315.4M | $191.7M | ||
| Q3 24 | $327.3M | $238.6M | ||
| Q2 24 | $315.7M | $308.4M |
| Q1 26 | — | $391.3M | ||
| Q4 25 | — | $392.8M | ||
| Q3 25 | — | $387.1M | ||
| Q2 25 | — | $394.1M | ||
| Q1 25 | — | $409.2M | ||
| Q4 24 | — | $403.9M | ||
| Q3 24 | — | $399.0M | ||
| Q2 24 | — | $436.8M |
| Q1 26 | — | $26.3M | ||
| Q4 25 | $88.3M | $-24.6M | ||
| Q3 25 | $73.7M | $-27.9M | ||
| Q2 25 | $73.1M | $-29.3M | ||
| Q1 25 | $53.2M | $-52.4M | ||
| Q4 24 | $57.0M | $-43.2M | ||
| Q3 24 | $92.9M | $-77.0M | ||
| Q2 24 | $102.9M | $-101.9M |
| Q1 26 | — | $806.6M | ||
| Q4 25 | $689.8M | $797.4M | ||
| Q3 25 | $669.3M | $787.7M | ||
| Q2 25 | $639.8M | $770.7M | ||
| Q1 25 | $596.7M | $802.3M | ||
| Q4 24 | $568.5M | $814.0M | ||
| Q3 24 | $561.5M | $867.3M | ||
| Q2 24 | $548.2M | $876.1M |
| Q1 26 | — | 14.87× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | — |
| Free Cash FlowOCF − Capex | $-18.7M | — |
| FCF MarginFCF / Revenue | -9.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $1.2M | ||
| Q3 25 | $1.0M | $40.8M | ||
| Q2 25 | $-32.4M | $35.6M | ||
| Q1 25 | $-43.4M | $-11.2M | ||
| Q4 24 | $-26.2M | $-26.6M | ||
| Q3 24 | $-18.6M | $12.4M | ||
| Q2 24 | $-30.1M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $1.1M | ||
| Q3 25 | $988.0K | $40.7M | ||
| Q2 25 | $-32.4M | $35.4M | ||
| Q1 25 | $-43.7M | $-11.2M | ||
| Q4 24 | $-26.2M | $-26.8M | ||
| Q3 24 | $-18.7M | $12.2M | ||
| Q2 24 | $-30.2M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | 1.0% | ||
| Q3 25 | 0.6% | 35.4% | ||
| Q2 25 | -21.6% | 33.0% | ||
| Q1 25 | -36.0% | -13.3% | ||
| Q4 24 | -22.1% | -35.6% | ||
| Q3 24 | -17.9% | 15.7% | ||
| Q2 24 | -34.6% | -34.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.1% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 13.79× | ||
| Q1 25 | — | -1.33× | ||
| Q4 24 | — | -0.87× | ||
| Q3 24 | — | 0.86× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
